NCT02079662

Brief Summary

This randomized clinical trial studies an integrative oncology (making changes in lifestyle and behavior) program in improving cancer-related outcomes in patients with stage II or III breast cancer undergoing radiation therapy. An integrative oncology program consisting of dietary recommendations, physical activity, stress management, social support, and control of environmental contaminants may modify cancer-related biological processes, influence long-term treatment results, and improve the quality of life of patients.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
57mo left

Started Jun 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jun 2013Dec 2030

Study Start

First participant enrolled

June 13, 2013

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 6, 2014

Completed
16.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

17.6 years

First QC Date

March 4, 2014

Last Update Submit

December 12, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • Disease-free survival (DFS)

    Will analyze DFS, using a multivariate comparison of DFS for each group using a Cox proportional hazards analysis. Will consider the following as potential covariates in the analysis (tumor and nodal status, menopausal status at diagnosis, tumor factors, treatment regimen, etc). Will obtain estimates for hazards ratios and 95% confidence intervals for the effect of the study arm and each covariate.

    Up to 5 years

  • Changes in biological pathways

    Will use generalized linear mixed model regression (GLMM). Separate sets of analyses will be conducted for each criterion variable. To select the best method for modeling the repeated measures, will use the methods of Wolfinger and statistics such as Akaike's and Schwarz's information criteria. Will also use either t tests or Wilcoxon two-sample tests to analyze these data, depending on their distributions.

    Baseline to 5 years

  • Changes in dietary patterns

    Will use GLMM. Separate sets of analyses will be conducted for each criterion variable. To select the best method for modeling the repeated measures, will use the methods of Wolfinger and statistics such as Akaike's and Schwarz's information criteria. Will also use either t tests or Wilcoxon two-sample tests to analyze these data, depending on their distributions.

    Baseline to 5 years

  • Changes in fitness levels

    Will use GLMM. Separate sets of analyses will be conducted for each criterion variable. To select the best method for modeling the repeated measures, will use the methods of Wolfinger and statistics such as Akaike's and Schwarz's information criteria. Will also use either t tests or Wilcoxon two-sample tests to analyze these data, depending on their distributions.

    Baseline to 5 years

  • Changes in heart rate variability

    Will use GLMM. Separate sets of analyses will be conducted for each criterion variable. To select the best method for modeling the repeated measures, will use the methods of Wolfinger and statistics such as Akaike's and Schwarz's information criteria. Will also use either t tests or Wilcoxon two-sample tests to analyze these data, depending on their distributions.

    Baseline to 5 years

  • Changes in quality of life (including fatigue and sleep disturbances)

    Will use GLMM. Separate sets of analyses will be conducted for each criterion variable. To select the best method for modeling the repeated measures, will use the methods of Wolfinger and statistics such as Akaike's and Schwarz's information criteria. Will also use either t tests or Wilcoxon two-sample tests to analyze these data, depending on their distributions.

    Baseline to 5 years

Study Arms (2)

Arm I (IO interventions)

EXPERIMENTAL

Patients undergo up to 7 different IO intervention sessions per week during their 6-week course of radiotherapy for between 1 and 3 hours each session, in addition to, up to 6 aerobic training sessions per week and one grocery store trip during the course of the program. IO intervention programs consist of nutritional coaching, behavioral therapy, yoga and meditation practice, resistance training, and a weekly meal sharing and cooking class. Patients then have weekly meetings with the study psychologist on the computer for 6 months, followed by a monthly meeting on the computer from 6-12 months, and 2 hour meetings at all follow-up appointments during the first year after radiotherapy.

Other: Behavioral, Psychological or Informational InterventionOther: Cognitive InterventionOther: Computer-Assisted InterventionOther: CounselingBehavioral: Exercise InterventionOther: Laboratory Biomarker AnalysisOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Arm II (standard of care)

ACTIVE COMPARATOR

Patients undergo standard of care.

Other: Best PracticeOther: Laboratory Biomarker AnalysisOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Interventions

Undergo IO intervention

Arm I (IO interventions)

Undergo standard of care

Also known as: standard of care, standard therapy
Arm II (standard of care)

Undergo IO intervention

Arm I (IO interventions)

Undergo IO intervention

Arm I (IO interventions)

Undergo counseling

Also known as: Counseling Intervention
Arm I (IO interventions)

Undergo IO intervention

Arm I (IO interventions)

Correlative studies

Arm I (IO interventions)Arm II (standard of care)

Ancillary studies

Also known as: Quality of Life Assessment
Arm I (IO interventions)Arm II (standard of care)

Ancillary studies

Arm I (IO interventions)Arm II (standard of care)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women with stage II or III breast cancer that will be scheduled to undergo a 4 to 6-week course of radiotherapy
  • Participants must be able to read, write, and speak English
  • Participants must be oriented to person, place, and time
  • Participants must also meet at least two of the following criteria related to lifestyle: 1) consume less than 3 servings of fruit and vegetable/day; 2) engage in less than 75 minutes moderate/vigorous activity per week, defined as anything that causes small increases in breathing or heart rate for a sustained amount of time (e.g., brisk walking, bicycling); and 3) engage in a mind-body practice less than 4 times a month
  • Participants must have a body mass index (BMI) of 24.45 or higher as assessed in the medical record

You may not qualify if:

  • Patients with a recurrent breast cancer diagnosis
  • Patients with another primary cancer diagnosis within 5 years of consent, not including non-melanoma skin cancers
  • Patients who have any major psychiatric diagnoses or thought disorder (e.g. schizophrenia, bi-polar disorder, dementia)
  • Patients with communication barriers (e.g., hard of hearing)
  • Patients with extreme mobility issues (e.g. unable to get in and out of a chair unassisted)
  • Patients with poorly or uncontrolled diabetes in the opinion of the physician(s)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Practice Guidelines as TopicStandard of CareCounseling

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Guidelines as TopicQuality Assurance, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationQuality Indicators, Health CareMental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Lorenzo Cohen

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2014

First Posted

March 6, 2014

Study Start

June 13, 2013

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Last Updated

December 17, 2025

Record last verified: 2025-12

Locations